Immunosignature Screening for Multiple Cancer Subtypes Based on Expression Rule

Liquid biopsy (i.e., fluid biopsy) involves a series of clinical examination approaches. Monitoring of cancer immunological status by the “immunosignature” of patients presents a novel method for tumor-associated liquid biopsy. The major work content and the core technological difficulties for the m...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lei, Pan, XiaoYong, Zeng, Tao, Zhang, Yu-Hang, Zhang, YunHua, Huang, Tao, Cai, Yu-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901955/
https://www.ncbi.nlm.nih.gov/pubmed/31850330
http://dx.doi.org/10.3389/fbioe.2019.00370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901955/
https://www.ncbi.nlm.nih.gov/pubmed/31850330
http://dx.doi.org/10.3389/fbioe.2019.00370

Ejemplares similares